Is mammography adequate for screening women with inherited BRCA mutations and low breast density?

被引:25
作者
Bigenwald, Rachel Z. [1 ]
Warner, Ellen [1 ]
Gunasekara, Anoma [2 ]
Hill, Kimberley A. [1 ]
Causer, Petrina A. [5 ]
Messner, Sandra J. [4 ]
Eisen, Andrea [1 ,4 ]
Plewes, Donald B. [2 ,6 ]
Narod, Steven A. [7 ]
Zhang, Liying [3 ]
Yaffe, Martin J. [2 ,6 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Div Med Oncol, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Div Imaging Res, Toronto, ON M4N 3M5, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Clin Trials & Epidemiol, Toronto, ON M4N 3M5, Canada
[4] Sunnybrook Hlth Sci Ctr, Div Prevent Oncol, Toronto, ON M4N 3M5, Canada
[5] Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON M4N 3M5, Canada
[6] Sunnybrook Hlth Sci Ctr, Dept Med Biophys, Toronto, ON M4N 3M5, Canada
[7] Univ Toronto, Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON, Canada
关键词
D O I
10.1158/1055-9965.EPI-07-0509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Several observational studies have shown that magnetic resonance imaging (MRI) is significantly more sensitive than mammography for screening women over age 25 at high risk for hereditary breast cancer; however, MRI is more costly and less specific than mammography. We sought to determine the extent to which the low sensitivity of mammography is due to greater breast density. Methods: Breast density was evaluated for all patients on a high-risk screening study who were diagnosed with breast cancer between November 1997 and July 2006. Density was measured in two ways: qualitatively using the four categories characterized by the Breast Imaging Reporting and Data System and quantitatively using a computer-aided technique and classified as (a) <= 10%, (b) 11% to 25%, (c) 26% to 50%, and (d) >50% density. Comparison of sensitivity of mammography (and MRI) for each individual density category and after combining the highest two and lowest two density categories was done using Fisher's exact test. Results: A total of 46 breast cancers [15 ductal carcinoma in situ (DCIS) and 31 invasive] were diagnosed in 45 women (42 with BRCA mutations). Mean age was 48.3 (range, 32-68) years. Overall, sensitivity of mammography versus MRI was 20% versus 87% for DCIS and 26% versus 90% for invasive cancer. There was a trend towards greater mammographic sensitivity for invasive cancer in women with fattier breasts compared with those with greater breast density (37-43% versus 8-12%; P = 0.1), but this trend was not seen for DCIS. Conclusion: It is necessary to add MRI to mammography for screening women with BRCA mutations even if their breast density is low.
引用
收藏
页码:706 / 711
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 2003, Breast imaging reporting and data system
[2]   QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY [J].
BOYD, NF ;
BYNG, JW ;
JONG, RA ;
FISHELL, EK ;
LITTLE, LE ;
MILLER, AB ;
LOCKWOOD, GA ;
TRITCHLER, DL ;
YAFFE, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :670-675
[3]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[4]   THE QUANTITATIVE-ANALYSIS OF MAMMOGRAPHIC DENSITIES [J].
BYNG, JW ;
BOYD, NF ;
FISHELL, E ;
JONG, RA ;
YAFFE, MJ .
PHYSICS IN MEDICINE AND BIOLOGY, 1994, 39 (10) :1629-1638
[5]   Meta-analysis of BRCA1 and BRCA2 penetrance [J].
Chen, Sining ;
Parmigiani, Giovanni .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1329-1333
[6]   Influence of computer-aided detection on performance of screening mammography [J].
Fenton, Joshua J. ;
Taplin, Stephen H. ;
Carney, Patricia A. ;
Abraham, Linn ;
Sickles, Edward A. ;
D'Orsi, Carl ;
Berns, Eric A. ;
Cutter, Gary ;
Hendrick, R. Edward ;
Barlow, William E. ;
Elmore, Joann G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (14) :1399-1409
[7]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[8]   The development of interval breast malignancies in patients with BRCA mutations [J].
Komenaka, IK ;
Ditkoff, BA ;
Joseph, KA ;
Russo, D ;
Gorroochurn, P ;
Ward, M ;
Horowitz, E ;
El-Tamer, MB ;
Schnabel, FR .
CANCER, 2004, 100 (10) :2079-2083
[9]   Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition [J].
Kriege, M ;
Brekelmans, CTM ;
Boetes, C ;
Besnard, PE ;
Zonderland, HM ;
Obdeijn, IM ;
Manoliu, RA ;
Kok, T ;
Peterse, H ;
Tilanus-Linthorst, MMA ;
Muller, SH ;
Meijer, S ;
Oosterwijk, JC ;
Beex, LVAM ;
Tollenaar, RAEM ;
de Koning, HJ ;
Rutgers, EJT ;
Klijn, JGM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :427-437
[10]   Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer [J].
Kuhl, CK ;
Schrading, S ;
Leutner, CC ;
Morakkabati-Spitz, N ;
Wardelmann, E ;
Fimmers, R ;
Kuhn, W ;
Schild, HH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8469-8476